GSK369796 Dihydrochloride
GSK369796 Dihydrochloride (N-tert-butylisoquine) is a cost-effective antimalarial candidate. It demonstrates activity in malaria research and inhibits the hERG potassium channel with an IC50 of 7.5 μM, a consideration for cardiac safety profiling in preclinical development.
Product Specifications
CAS Number
1010411-21-8
Product Name Alternative
GSK 369796, GSK 369796 Dihydrochloride, GSK369796, GSK-369796, GSK369796 Dihydrochloride, GSK-369796 Dihydrochloride, Parasite, N-tert-butylisoquine, inhibit, KcsA, Inhibitor, Potassium Channel, PotassiumChannel, potassium ion channel
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery
Purity
98.00% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.66 mM) ; DMSO:75 mg/mL (174.91 mM)
Smiles
Cl.Cl.CC (C) (C) NCc1ccc (Nc2ccnc3cc (Cl) ccc23) cc1O
Molecular Formula
C20H24Cl3N3O
Molecular Weight
428.78
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
